Disease Modifying Therapies in Alzheimer's Disease: Current Evidence and Clinical Considerations

Disease-modifying therapies represent a paradigm shift in Alzheimer’s care. This session reviews current evidence supporting these therapies, including mechanisms of action, clinical trial data, and real-world considerations such as patient selection, safety monitoring, and health system readiness.